Neuro Bio
Pre-clinicalA biotechnology company developing novel therapeutics targeting neurodegenerative diseases like Alzheimer's.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $40M
About
A biotechnology company developing novel therapeutics targeting neurodegenerative diseases like Alzheimer's.
DiagnosticsSmall Molecules
Funding History
2Total raised:$40M
Series A$30MJun 15, 2021
Seed$10MJun 15, 2018